Robotic Automation of Cell Isolation to Streamline Cell Therapy Manufacturing

Explore how robotic automation is revolutionizing cell therapy manufacturing by addressing manual bottlenecks that have long constrained the industry in this 32-minute webinar. Learn from Dr. Fred Parietti, Co-founder and CEO of Multiply Labs, as he demonstrates how robotic biomanufacturing clusters are transforming cleanroom operations through standardized workflows and seamless integration with GMP-compliant instruments. Discover the practical implementation of robotic automation through a detailed case study featuring the integration of GenScript CytoSinct™ 1000 into the Multiply Labs robotic platform, showcasing a fully automated cell isolation workflow that delivers enhanced consistency, streamlined operations, and shortened production timelines. Understand how this technology dramatically improves the unit economics of cell therapy manufacturing by increasing throughput and accelerating timelines while overcoming regulatory and process barriers through the use of market-leading GMP instruments already deployed in the industry. Gain insights into the specific mechanisms of robotic cell isolation automation and how this approach enables parallelism for higher throughput, ultimately pointing toward a new standard for scalable, automated cell therapy production that goes beyond incremental efficiency improvements.